logo

Health News

Share
vitamind-jan31.jpgVitamin D is very essential for healthy bones and to prevent osteoporosis. Known as the "Sunshine Vitamin, as sunlight is the main source, the deficiency of Vitamin D has been associated with fatigue, depressed mood and bone, and muscle pain, to name a few.
Read More

Canadian marijuana producer Aurora Cannabis Inc. (ACB, ACB.TO) has agreed to acquire the remaining 48 percent stake in Hempco Food and Fiber Inc. (HEMP.V) that it does not already own, in a deal that values Hempco at about C$63.4 million. Shares of Hempco gained more than 10 percent in Tuesday's trading. Aurora...
Read More
fluemen-july19.jpg Women are said to experience a more severe outcome from influenza A virus infection and recover slower than men, even when the viral load is the same in both the genders. Read More

Alzheimer's Tau Protein Raises Risk Of Cancer Too: Study



One of the hallmarks of Alzheimer's disease is the presence of neurofibrillary tangles inside neurons - i.e., the cells that make up the brain and the nervous system. The neurofibrillary tangles are composed of mutated Tau protein. So Tau is an attractive target for developing a new Alzheimer's therapy.
Read More
brain-may13.jpg

Researchers Find A Chink In Deadly Glioblastoma's Armour



Glioblastoma is an aggressive type of cancer in adults that primarily develops in the cerebral hemispheres of the brain. There is no cure yet for glioblastoma. A discovery by researchers from the University of Helsinki led by Professor Pirjo Laakkonen raises hopes of a potential treatment for this lethal brain cancer.
Read More
pigs-april18.jpg

No Piggy Tale: Some Brain Functions Restored Even Hours After Death



The conventional wisdom is that if the brain cells of humans and other mammals are deprived of oxygen for 4-5 min, they begin to die, and that the loss of brain functions after death is irreversible. But the findings of a study conducted by Yale University researchers challenge these long-held assumptions.
Read More
mekinist-april30.jpgScientists at the Université de Montréal and CHU Sainte-Justine Research Cente are said to have made a discovery, which could be a promising treatment for patients with Noonan Syndrome.
Read More
Follow RTT


FDA Calendar
Event DateSymbolDrug NameEvent Name
08/19/19NBRVLefamulin (NDA) FDA decision on oral and IV formulations of Lefamulin for bacterial pneumonia
08/16/19VNDAHETLIOZ (sNDA)FDA decision on HETLIOZ for the expanded indication of jet lag disorder
08/03/19DSKYF.PKPexidartinib (NDA)FDA decision on Pexidartinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor
07/06/19KPTISelinexor (NDA)FDA decision on Selinexor for patients with refractory multiple myeloma
06/30/19DOVADOPTELET (sNDA)FDA decision on DOPTELET for chronic immune thrombocytopenia
06/28/19ALXNSoliris (sNDA)FDA decision on Soliris for the treatment of neuromyelitis optica spectrum disorder
View All